Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
基本信息
- 批准号:8895208
- 负责人:
- 金额:$ 6.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2015-09-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAdverse effectsAffectAmino Acid TransporterAnti-Inflammatory AgentsAntioxidantsBindingBiogenesisBiological PreservationCell DeathCellsCellular StressDNADataDiseaseElderlyEnvironmentFemaleFetal DevelopmentFetal GrowthFetal Growth RetardationFetusFunctional disorderGene ExpressionGene TargetingGenesGenus HippocampusHealthHormonesHumanHuman Chorionic GonadotropinHypoxiaInflammationInflammatoryInflammatory ResponseLifeLinkMeasuresMediatingMessenger RNAMetabolismMethodsMicroRNAsMitochondriaMolecularObesityOverweightOxidative StressPathway interactionsPlacentaPlayPre-EclampsiaPregnancyPregnancy OutcomeProductionProteinsPublishingReactive Oxygen SpeciesRegulationReportingRespirationReverse Transcriptase Polymerase Chain ReactionRoleSpecificityStressSulofenurTestingTissuesTranslational RepressionUntranslated RNAUp-RegulationWeightWomanWorkbaseextracellularfetal programmingimprovedinnovationloss of functionmRNA Transcript Degradationmalemitochondrial dysfunctionmutantnew technologynormotensivenoveloffspringoverexpressionp65programspromoterpublic health relevanceresearch studyresponsesexual dimorphismsyncytintherapeutic targettranscription factortrophoblast
项目摘要
DESCRIPTION (provided by applicant): An adverse intrauterine environment, seen in pregnancies complicated by preeclampsia, obesity or intrauterine growth restriction (IUGR), programs the offspring for disease in later life. Placental function regulates fetal growth and development, transducing the maternal and uterine environment to the fetus, and mediating fetal programming. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through translational repression or mRNA degradation. We found significantly increased expression of miR- 210 in placentas from pregnancies complicated by severe preeclampsia or with increased maternal adiposity but the latter only in the presence of a female fetus. This suggests that miR-210 plays a pivotal role in the placental response to an adverse intrauterine environment, but with a sexually dimorphic influence in the obese environment. Using novel technology for measuring mitochondrial energetics, we described significant mitochondrial dysfunction in placentas of preeclamptic or obese women and that gain- and loss-of-function of miR-210 in primary trophoblast resulted in loss or preservation of mitochondrial activity respectively. We have recently shown that the transcription factor NFkB, which mediates many inflammatory responses, is increased in the placenta with maternal adiposity and binds to the mir-210 promoter but again only in the placenta of a female fetus. NFkB action has previously shown to be sexually dimorophic. The overall objective of this proposal is to determine the molecular basis by which miR-210 regulates mitochondrial and in turn, placental function in pregnancies complicated by preeclampsia, maternal obesity or IUGR. The central hypothesis is that hypoxia, inflammation or oxidative stress seen in such pregnancies increase miR-210 expression, which represses mitochondrial respiration causing placental dysfunction. This hypothesis will be tested through three Specific Aims: 1. Determine the role of miR-210 in mitochondrial and placental function. 2. Determine the role of NFkB in mediating the effect of trophoblast miR-210 under adverse conditions, and 3. Identify novel miR-210 target genes in trophoblast and define their role in mitochondrial and placental function. In all cases we will study the sexual dimorphism of effect. This proposal is innovative in studying the role of miR-210 in mitochondrial and placental function in normal and adverse conditions. We will determine if hypoxia, inflammation and oxidative stress act via the transcription factor NFkB governing miR-210 expression, identify novel miR-210 target genes controlling trophoblast mitochondrial function and if manipulation of mitochondrial function alters placental function.
描述(由申请人提供):不良的宫内环境,见于妊娠合并先兆子痫,肥胖或宫内生长受限(IUGR),使后代在以后的生活中有疾病。胎盘功能调节胎儿的生长发育,将母体和子宫环境传递给胎儿,并介导胎儿程序设计。MicroRNAs (miRNAs)是一种小的非编码rna,通过翻译抑制或mRNA降解来调节基因表达。我们发现miR- 210在伴有严重先兆子痫或母体肥胖的孕妇胎盘中的表达显著增加,但后者仅在女性胎儿存在时才会增加。这表明miR-210在胎盘对不良宫内环境的反应中起关键作用,但在肥胖环境中具有性别二态影响。利用测量线粒体能量的新技术,我们描述了子痫前期或肥胖妇女胎盘中显著的线粒体功能障碍,以及初级滋养细胞中miR-210功能的增加和丧失分别导致线粒体活性的丧失或保留。我们最近发现介导许多炎症反应的转录因子NFkB在母体肥胖的胎盘中增加,并与mir-210启动子结合,但同样仅在女性胎儿的胎盘中。NFkB的作用以前被证明是两性二异形的。本提案的总体目标是确定miR-210调节线粒体的分子基础,进而调节伴有先兆子痫、产妇肥胖或IUGR的妊娠中胎盘功能。核心假设是,这种妊娠中出现的缺氧、炎症或氧化应激会增加miR-210的表达,从而抑制线粒体呼吸,导致胎盘功能障碍。这一假设将通过三个具体目标进行检验:1。确定miR-210在线粒体和胎盘功能中的作用。2. 2 .确定NFkB在逆境条件下介导滋养细胞miR-210的作用;在滋养细胞中鉴定新的miR-210靶基因并确定其在线粒体和胎盘功能中的作用。在所有情况下,我们将研究效应的两性二态性。该提议在研究miR-210在正常和不良条件下对线粒体和胎盘功能的作用方面具有创新性。我们将确定缺氧、炎症和氧化应激是否通过调控miR-210表达的转录因子NFkB起作用,确定控制滋养层线粒体功能的新型miR-210靶基因,以及线粒体功能的操纵是否会改变胎盘功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LESLIE MYATT其他文献
LESLIE MYATT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LESLIE MYATT', 18)}}的其他基金
Placental Mitochondrial Function in Gestational Diabetes
妊娠糖尿病中的胎盘线粒体功能
- 批准号:
10396015 - 财政年份:2018
- 资助金额:
$ 6.01万 - 项目类别:
Placental Mitochondrial Function in Gestational Diabetes
妊娠糖尿病中的胎盘线粒体功能
- 批准号:
9920017 - 财政年份:2018
- 资助金额:
$ 6.01万 - 项目类别:
Effects of a Maternal Obesogenic Environment on DNA Methylation in the Placenta
母体肥胖环境对胎盘 DNA 甲基化的影响
- 批准号:
8707875 - 财政年份:2013
- 资助金额:
$ 6.01万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
9353444 - 财政年份:2013
- 资助金额:
$ 6.01万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
8741981 - 财政年份:2013
- 资助金额:
$ 6.01万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
8650502 - 财政年份:2013
- 资助金额:
$ 6.01万 - 项目类别:
Effects of a Maternal Obesogenic Environment on DNA Methylation in the Placenta
母体肥胖环境对胎盘 DNA 甲基化的影响
- 批准号:
9276325 - 财政年份:2013
- 资助金额:
$ 6.01万 - 项目类别:
Effects of a Maternal Obesogenic Environment on DNA Methylation in the Placenta
母体肥胖环境对胎盘 DNA 甲基化的影响
- 批准号:
8491926 - 财政年份:2013
- 资助金额:
$ 6.01万 - 项目类别:
Molecular Mechanisms Linking Placental Nutrient Sensing and Fetal Programming
连接胎盘营养感应和胎儿编程的分子机制
- 批准号:
8432440 - 财政年份:2012
- 资助金额:
$ 6.01万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 6.01万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 6.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 6.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 6.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 6.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 6.01万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 6.01万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 6.01万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 6.01万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 6.01万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




